BWX Technologies, Inc. (NYSE: BWXT) has successfully completed its acquisition of Kinectrics, Inc. as of May 20, 2025. This strategic acquisition, initially announced in January, is expected to enhance BWXT's capabilities across the commercial nuclear power market and medical isotopes sector. The acquisition nearly doubles the workforce of BWXT's Commercial Operations group and broadens its portfolio of products and services. Kinectrics will now operate as a BWXT subsidiary, with David Harris continuing as president & CEO, reporting to John MacQuarrie, BWXT president of Commercial Operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.